207 related articles for article (PubMed ID: 27422767)
21. Necrolytic migratory erythema associated with glucagonoma syndrome diagnosed by ⁶⁸Ga-DOTANOC PET-CT.
Sahoo MK; Gupta S; Singh I; Pahwa S; Durgapal P; Bal CS
Asia Pac J Clin Oncol; 2014 Jun; 10(2):190-3. PubMed ID: 23279825
[TBL] [Abstract][Full Text] [Related]
22. [Pseudoglucagonoma syndrome. Case report, therapeutic possibilities and hypotheses on the etiology].
Ossowski B; Baum C
Hautarzt; 1995 Mar; 46(3):173-6. PubMed ID: 7759243
[TBL] [Abstract][Full Text] [Related]
23. Rare presentation of endocrine pancreatic tumour: a case of glucagonoma without necrolytic migratory erythema?
Manes G; Pellegrini A; Riccardi F; Uomo G
Ital J Gastroenterol; 1995 Jun; 27(5):248-9. PubMed ID: 8541575
[TBL] [Abstract][Full Text] [Related]
24. Necrolytic migratory erythema: first symptom of a glucagonoma. A case report.
Du Jardin P; Cools P; Van der Stighelen Y
Acta Chir Belg; 2004 Aug; 104(4):468-70. PubMed ID: 15469167
[TBL] [Abstract][Full Text] [Related]
25. Glucagonoma syndrome.
Bloom SR; Polak JM
Am J Med; 1987 May; 82(5B):25-36. PubMed ID: 2884877
[TBL] [Abstract][Full Text] [Related]
26. The glucagonoma syndrome: a review of its features and discussion of new perspectives.
Chastain MA
Am J Med Sci; 2001 May; 321(5):306-20. PubMed ID: 11370794
[TBL] [Abstract][Full Text] [Related]
27. [Glucagonoma syndrome without diabetes mellitus].
Mikkelsen CS; Mikkelsen DB; Vestergaard V; Clemmensen O; Nielsen HO; Bygum A
Ugeskr Laeger; 2008 Nov; 170(47):3876. PubMed ID: 19014744
[TBL] [Abstract][Full Text] [Related]
28. [Glucagonoma: evolution and treatment].
Carvajal C; Azabache V; Lobos P; Ibarra A
Rev Med Chil; 2002 Jun; 130(6):671-6. PubMed ID: 12194691
[TBL] [Abstract][Full Text] [Related]
29. Dermatitis, glossitis, stomatitis, cheilitis, anemia and weight loss: a classic presentation of pancreatic glucagonoma.
Povoski SP; Zaman SA; Ducatman BS; McFadden DW
W V Med J; 2002; 98(1):12-4. PubMed ID: 11941895
[TBL] [Abstract][Full Text] [Related]
30. Glucagonoma syndrome: A case report.
Wei J; Lin S; Wang C; Wu J; Qian Z; Dai C; Jiang K; Miao YI
Oncol Lett; 2015 Aug; 10(2):1113-1116. PubMed ID: 26622635
[TBL] [Abstract][Full Text] [Related]
31. Necrolytic migratory erythema with myelodysplastic syndrome without glucagonoma.
Technau K; Renkl A; Norgauer J; Ziemer M
Eur J Dermatol; 2005; 15(2):110-2. PubMed ID: 15757825
[TBL] [Abstract][Full Text] [Related]
32. Peripheral amino acid and fatty acid infusion for the treatment of necrolytic migratory erythema in the glucagonoma syndrome.
Alexander EK; Robinson M; Staniec M; Dluhy RG
Clin Endocrinol (Oxf); 2002 Dec; 57(6):827-31. PubMed ID: 12460334
[TBL] [Abstract][Full Text] [Related]
33. [Diagnosis and treatment of glucagonoma: report of one case].
Cheng H; Chen M; Yang G
Nan Fang Yi Ke Da Xue Xue Bao; 2013 Apr; 33(4):618-insidebackcover. PubMed ID: 23644134
[TBL] [Abstract][Full Text] [Related]
34. Malign cystic glucagonoma presented with diabetic ketoacidosis: case report with an update.
Fenkci SM; Fidan Yaylali G; Sermez Y; Akdam H; Sabir N; Kiraç S
Endocr Relat Cancer; 2005 Jun; 12(2):449-54. PubMed ID: 15947115
[TBL] [Abstract][Full Text] [Related]
35. Glucagonoma syndrome and necrolytic migratory erythema.
Lobo I; Carvalho A; Amaral C; Machado S; Carvalho R
Int J Dermatol; 2010 Jan; 49(1):24-9. PubMed ID: 20465606
[TBL] [Abstract][Full Text] [Related]
36. Primary malignant hepatic glucagonoma: an autopsy case.
Obi N; Katabami T; Obi R; Odanaka M; Sasano K; Tanaka Y
Endocr J; 2009; 56(5):715-9. PubMed ID: 19367016
[TBL] [Abstract][Full Text] [Related]
37. Necrolytic migratory erythaema and glucagonoma syndrome.
Marogy G; De Man M; Verslype C
Acta Clin Belg; 2009; 64(1):70-1. PubMed ID: 19317246
[No Abstract] [Full Text] [Related]
38. Hyperglucagonaemia and necrolytic migratory erythema in cirrhosis--possible pseudoglucagonoma syndrome.
Doyle JA; Schroeter AL; Rogers RS
Br J Dermatol; 1979 Nov; 101(5):581-7. PubMed ID: 518828
[TBL] [Abstract][Full Text] [Related]
39. Glucagonoma: From skin lesions to the neuroendocrine component (Review).
Sandru F; Carsote M; Albu SE; Valea A; Petca A; Dumitrascu MC
Exp Ther Med; 2020 Oct; 20(4):3389-3393. PubMed ID: 32905095
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
